She is presently Associate Professor of Pharmacology, Head of the Pharmacology Teaching Unit in the Faculty of Medicine, and member in the Betz Center for Injury Prevention at the Hebrew University of Jerusalem. Her research interests include mechanisms of brain damage and potential repair in traumatic brain injury, using in vivo and in vitro model systems.
Special emphasis is given to inflammatory mediators such as cytokines and reactive oxygen specials.
She is presently Professor of Molecular Biology and Head of the Eric Roland Center for Neurodegenerative Diseases at the Hebrew University of Jerusalem. Her research interests include transgenic and antisense approaches for studying stress insults, with special emphasis on the multifaceted involvement of acetylcholinesterase in stress responses. Emergency intervention following CHI should therefore strive to improve survival, promote recovery, and prevent delayed neuropathologies. Furthermore, antisense treatment reduced the number of dead CA3 hippocampal neurons in injured mice, and facilitated neurological recovery as determined by performance in tests of neuromotor coordination. These findings demonstrate the potential of antisense therapeutics in treating acute injury, and suggest antisense prevention of AChE-R overproduction to mitigate the detrimental consequences of various traumatic brain insults.